Home / Latest Reports / Preventable Vaccines Market

Preventable Vaccines Market By Type and Application - Global Industry Analysis And Forecast To 2027

Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101366

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Preventable Vaccines Market By Type (Pediatric Preventable Vaccines and Adult Preventable Vaccines) and Application (Virus Diseases and Bacterial Diseases) - Global Industry Analysis And Forecast To 2027

Industry Outlook

Preventable Vaccines are those, which are used to avoid or prevent any disease from occurring. Some of the vaccine preventable serious disorders are; hepatitis B, influenza, pertussis, poliomyelitis, diphtheria, meningitis, measles, mumps, yellow fever, neonatal tetanus, etc. Increase in immunization programs by government is seen is various economies to suppress serious disorders. Factors for the increasing use of Preventable Vaccines are; development in biomedical field, technical development in the manufacturing, rising occurrence of vaccine preventable disorders, etc. Therefore, the Preventable Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global Preventable Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Preventable Vaccines Market is based on segment, by Type the market is segmented into Pediatric Preventable Vaccines and Adult Preventable Vaccines; and by Application the market is segmented into Virus Diseases and Bacterial Diseases.

  • Preventable Vaccines Market, By Type
  • Pediatric Preventable Vaccines
  • Adult Preventable Vaccines
  • Preventable Vaccines Market, By Application
  • Virus Diseases
  • Bacterial Diseases

Regional Insights

On a global front, the Preventable Vaccines Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Preventable Vaccines Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Sanofi, GlaxoSmithKline, Mitsubishi Tanabe Pharma, Merck, LG Life Sciences, Novartis, AstraZeneca, Emergent Biosciences Inc., Pfizer, Bharat Biotech, Abbott, Bavarian Nordic and Roche. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Sanofi
  • GlaxoSmithKline
  • Mitsubishi Tanabe Pharma
  • Merck
  • LG Life Sciences
  • Novartis
  • AstraZeneca
  • Emergent Biosciences Inc.
  • Pfizer
  • Bharat Biotech
  • Abbott
  • Bavarian Nordic
  • Roche

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Preventable Vaccines Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o   Pediatric Preventable Vaccines

o   Adult Preventable Vaccines

·         Preventable Vaccines Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o   Virus Diseases

o   Bacterial Diseases

·         Preventable Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Preventable Vaccines Market, By Country

o   U.S. Preventable Vaccines Market

o   Canada Preventable Vaccines Market

o   Mexico Preventable Vaccines Market

o   Europe

§  Europe Preventable Vaccines Market, By Country

o   Germany Preventable Vaccines Market

o   UK Preventable Vaccines Market

o   France Preventable Vaccines Market

o   Russia Preventable Vaccines Market

o   Italy Preventable Vaccines Market

o   Rest of Europe Preventable Vaccines Market

o   Asia-Pacific

§  Asia-Pacific Preventable Vaccines Market, By Country

o   China Preventable Vaccines Market

o   Japan Preventable Vaccines Market

o   South Korea  Preventable Vaccines Market

o   India Preventable Vaccines Market

o   Southeast Asia Preventable Vaccines Market

o   Rest of Asia-Pacific Preventable Vaccines Market

o   South America

§  South America Preventable Vaccines Market, By Country

o   Brazil Preventable Vaccines Market

o   Argentina Preventable Vaccines Market

o   Columbia Preventable Vaccines Market

o   Rest of South America Preventable Vaccines Market

o   Middle East and Africa

§  Middle East and Africa Preventable Vaccines Market, By Country

o   Saudi Arabia Preventable Vaccines Market

o   UAE Preventable Vaccines Market

o   Egypt Preventable Vaccines Market

o   Nigeria Preventable Vaccines Market

o   South Africa Preventable Vaccines Market

o   Rest of MEA Preventable Vaccines Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Preventable Vaccines  Market, By Type

5.1.     Introduction

5.2.     Global Preventable Vaccines  Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Preventable Vaccines  Revenue and Revenue Share by Type (2017-2027)

5.3.     Pediatric Preventable Vaccines

5.3.1.  Global Pediatric Preventable Vaccines Revenue and Growth Rate (2017-2027)

5.4.     Adult Preventable Vaccines

5.4.1.  Global Adult Preventable Vaccines Revenue and Growth Rate (2017-2027)

6.       Preventable Vaccines  Market, By Application

6.1.     Introduction

6.2.     Global Preventable Vaccines  Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Preventable Vaccines  Revenue and Revenue Share by Application (2017-2027)

6.3.     Virus Diseases

6.3.1.  Global Virus Diseases  Revenue and Growth Rate (2017-2027)

6.4.     Bacterial Diseases

6.4.1.  Global Bacterial Diseases Revenue and Growth Rate (2017-2027)

7.       Preventable Vaccines  Market, By Region

7.1.     Introduction

7.2.     Global Preventable Vaccines  Revenue and Market Share by Regions

7.2.1.  Global Preventable Vaccines  Revenue by Regions (2017-2027)

7.3.     North America Preventable Vaccines  by Countries

7.3.1.  North America Preventable Vaccines  Revenue and Growth Rate (2017-2027)

7.3.2.  North America Preventable Vaccines  Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Preventable Vaccines  by Countries

7.4.1.  Europe Preventable Vaccines  Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Preventable Vaccines  Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Preventable Vaccines  by Countries

7.5.1.  Asia-Pacific Preventable Vaccines  Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Preventable Vaccines  Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Preventable Vaccines  by Countries

7.6.1.  South America Preventable Vaccines  Revenue and Growth Rate (2017-2027)

7.6.2.  South America Preventable Vaccines  Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Preventable Vaccines  by Countries

7.7.1.  Middle East and Africa Preventable Vaccines  Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Preventable Vaccines  Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Sanofi

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     GlaxoSmithKline

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Mitsubishi Tanabe Pharma

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Merck

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     LG Life Sciences

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Novartis

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     AstraZeneca

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Emergent Biosciences Inc.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Pfizer 

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Bharat Biotech

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Abbott

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

8.12. Bavarian Nordic

8.12.1.      Business Overview

8.12.2.       Service Portfolio

8.12.3.      Strategic Developments

8.12.4.       Revenue and Market Share

8.13. Roche

8.13.1.      Business Overview

8.13.2.       Service Portfolio

8.13.3.      Strategic Developments

8.13.4.       Revenue and Market Share

9.       Global Preventable Vaccines  Market Competition, by Manufacturer

9.1.     Global Preventable Vaccines  Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Preventable Vaccines  Price By Region (2017-2017)

9.3.     Top 5 Preventable Vaccines  Manufacturer Market Share

9.4.     Market Competition Trend

10.    Preventable Vaccines  Market Forecast (2017-2027)

10.1. Global Preventable Vaccines  Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Preventable Vaccines  Market Forecast by Regions (2017-2027)

10.2.1.      North America Preventable Vaccines  Market Forecast (2017-2027)

10.2.1.1. United States Preventable Vaccines  Market Forecast (2017-2027)

10.2.1.2. Canada Preventable Vaccines  Market Forecast (2017-2027)

10.2.1.3. Mexico Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.      Europe Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.1. Germany Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.2. France Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.3. UK Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.4. Russia Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.5. Italy Preventable Vaccines  Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.1. China Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.2. Japan Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.3. Korea Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.4. India Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Preventable Vaccines  Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Preventable Vaccines  Market Forecast (2017-2027)

10.2.4.      South America Preventable Vaccines  Market Forecast (2017-2027)

10.2.4.1. Brazil Preventable Vaccines  Market Forecast (2017-2027)

10.2.4.2. Argentina Preventable Vaccines  Market Forecast (2017-2027)

10.2.4.3. Columbia Preventable Vaccines  Market Forecast (2017-2027)

10.2.4.4. Rest of South America Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.3. Egypt Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.4. Nigeria Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.5. South Africa Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.6. Turkey Preventable Vaccines  Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Preventable Vaccines  Market Forecast (2017-2027)

10.3. Preventable Vaccines  Market Forecast by Type (2017-2027)

10.3.1.      Preventable Vaccines  Forecast by Type (2017-2027)

10.3.2.      Preventable Vaccines  Market Share Forecast by Type (2017-2027)

10.4. Preventable Vaccines  Market Forecast by Application (2017-2027)

10.4.1.      Preventable Vaccines  Forecast by Application (2017-2027)

10.4.2.      Preventable Vaccines  Market Share Forecast by Application (2017-2027)

List of Tables

List of Tables and Figures
Figure United States Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Preventable Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Preventable Vaccines Revenue and Revenue Share by Type (2017-2018)
Figure Global Pediatric Preventable Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Adult Preventable Vaccines Revenue and Growth Rate (2017-2018)
Table Global Preventable Vaccines Revenue and Revenue Share by Application (2017-2018)
Figure Global Virus Diseases Revenue and Growth Rate (2017-2018)
Figure Global Bacterial Diseases Revenue and Growth Rate (2017-2018)
Table Global Preventable Vaccines Revenue by Regions (2017-2018)
Figure North America Preventable Vaccines Growth Rate (2017-2018)
Figure North America Preventable Vaccines Revenue and Growth Rate (2017-2018)
Figure North America Preventable Vaccines by Countries (2017-2018)
Figure North America Preventable Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure United States Preventable Vaccines Growth Rate (2017-2018)
Figure United States Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Preventable Vaccines Growth Rate (2017-2018)
Figure Canada Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Preventable Vaccines Growth Rate (2017-2018)
Figure Mexico Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Preventable Vaccines Growth Rate (2017-2018)
Figure Europe Preventable Vaccines Revenue and Growth Rate (2017-2018)
Figure Europe Preventable Vaccines by Countries (2017-2018)
Figure Europe Preventable Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Germany Preventable Vaccines Growth Rate (2017-2018)
Figure Germany Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Preventable Vaccines Growth Rate (2017-2018)
Figure France Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Preventable Vaccines Growth Rate (2017-2018)
Figure UK Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Preventable Vaccines Growth Rate (2017-2018)
Figure Russia Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Preventable Vaccines Growth Rate (2017-2018)
Figure Italy Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Preventable Vaccines Growth Rate (2017-2018)
Figure Rest of Europe Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Preventable Vaccines Growth Rate (2017-2018)
Figure Asia-Pacific Preventable Vaccines Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Preventable Vaccines by Countries (2017-2018)
Figure Asia-Pacific Preventable Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure China Preventable Vaccines Growth Rate (2017-2018)
Figure China Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Preventable Vaccines Growth Rate (2017-2018)
Figure Japan Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Preventable Vaccines Growth Rate (2017-2018)
Figure Korea Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Preventable Vaccines Growth Rate (2017-2018)
Figure India Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Preventable Vaccines Growth Rate (2017-2018)
Figure Southeast Asia Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preventable Vaccines Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Preventable Vaccines Growth Rate (2017-2018)
Figure South America Preventable Vaccines Revenue and Growth Rate (2017-2018)
Figure South America Preventable Vaccines by Countries (2017-2018)
Figure South America Preventable Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Preventable Vaccines Growth Rate (2017-2018)
Figure Brazil Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Preventable Vaccines Growth Rate (2017-2018)
Figure Argentina Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Preventable Vaccines Growth Rate (2017-2018)
Figure Columbia Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Preventable Vaccines Growth Rate (2017-2018)
Figure Rest of South America Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Preventable Vaccines Growth Rate (2017-2018)
Figure Middle East and Africa Preventable Vaccines Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Preventable Vaccines by Countries (2017-2018)
Figure Middle East and Africa Preventable Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Preventable Vaccines Growth Rate (2017-2018)
Figure Saudi Arabia Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Preventable Vaccines Growth Rate (2017-2018)
Figure United Arab Emirates Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Preventable Vaccines Growth Rate (2017-2018)
Figure Egypt Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Preventable Vaccines Growth Rate (2017-2018)
Figure Nigeria Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Preventable Vaccines Growth Rate (2017-2018)
Figure South Africa Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Preventable Vaccines Growth Rate (2017-2018)
Figure Turkey Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preventable Vaccines Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preventable Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Table Sanofi Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mitsubishi Tanabe Pharma Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table LG Life Sciences Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Emergent Biosciences Inc. Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bharat Biotech Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bavarian Nordic Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Preventable Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Preventable Vaccines Market Share by Manufacturer
Figure Global Preventable Vaccines Revenue and Market Share by Manufacturer
Table Global Preventable Vaccines Price by Region (2017-2017)
Figure Top 5 Preventable Vaccines Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Preventable Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
Table Preventable Vaccines Market Forecast by Regions (2018-2025)
Figure North America Preventable Vaccines Market Forecast (2018-2025)
Figure United States Preventable Vaccines Market Forecast (2018-2025)
Figure Canada Preventable Vaccines Market Forecast (2018-2025)
Figure Mexico Preventable Vaccines Market Forecast (2018-2025)
Figure Europe Preventable Vaccines Market Forecast (2018-2025)
Figure Germany Preventable Vaccines Market Forecast (2018-2025)
Figure France Preventable Vaccines Market Forecast (2018-2025)
Figure UK Preventable Vaccines Market Forecast (2018-2025)
Figure Russia Preventable Vaccines Market Forecast (2018-2025)
Figure Italy Preventable Vaccines Market Forecast (2018-2025)
Figure Rest of Europe Preventable Vaccines Market Forecast (2018-2025)
Figure Asia-Pacific Preventable Vaccines Market Forecast (2018-2025)
Figure China Preventable Vaccines Market Forecast (2018-2025)
Figure Japan Preventable Vaccines Market Forecast (2018-2025)
Figure Korea Preventable Vaccines Market Forecast (2018-2025)
Figure India Preventable Vaccines Market Forecast (2018-2025)
Figure Southeast Asia Preventable Vaccines Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Preventable Vaccines Market Forecast (2018-2025)
Figure South America Preventable Vaccines Market Forecast (2018-2025)
Figure Brazil Preventable Vaccines Market Forecast (2018-2025)
Figure Argentina Preventable Vaccines Market Forecast (2018-2025)
Figure Columbia Preventable Vaccines Market Forecast (2018-2025)
Figure Rest of South America Preventable Vaccines Market Forecast (2018-2025)
Figure Middle East and Africa Preventable Vaccines Market Forecast (2018-2025)
Figure Saudi Arabia Preventable Vaccines Market Forecast (2018-2025)
Figure United Arab Emirates Preventable Vaccines Market Forecast (2018-2025)
Figure Egypt Preventable Vaccines Market Forecast (2018-2025)
Figure Nigeria Preventable Vaccines Market Forecast (2018-2025)
Figure South Africa Preventable Vaccines Market Forecast (2018-2025)
Figure Turkey Preventable Vaccines Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Preventable Vaccines Market Forecast (2018-2025)
Figure Global Preventable Vaccines Forecast by Type (2018-2025)
Figure Global Preventable Vaccines Market Share Forecast by Type (2018-2025)
Figure Global Preventable Vaccines Forecast by Type (2018-2025)
Figure Global Preventable Vaccines Forecast by Application (2018-2025)
Figure Global Preventable Vaccines Market Share Forecast by Application (2018-2025)
Figure Global Preventable Vaccines Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample